Antigens, CD86
-
Subject Areas on Research
- Activation of human B cells by phosphorothioate oligodeoxynucleotides.
- Adjuvanticity and protective immunity of Plasmodium yoelii nigeriensis blood-stage soluble antigens encapsulated in fusogenic liposome.
- CD40 ligand-dependent T cell activation: requirement of B7-CD28 signaling through CD40.
- CD7 and CD28 are required for murine CD4+CD25+ regulatory T cell homeostasis and prevention of thyroiditis.
- CD86 (B7-2) can function to drive MHC-restricted antigen-specific CTL responses in vivo.
- Cellular FLIP Inhibits Myeloid Cell Activation by Suppressing Selective Innate Signaling.
- Cellular interaction in germinal centers. Roles of CD40 ligand and B7-2 in established germinal centers.
- Characterization of dendritic-like cells derived from t(9;22) acute lymphoblastic leukemia blasts.
- Combination induction therapy with monoclonal antibodies specific for CD80, CD86, and CD154 in nonhuman primate renal transplantation.
- Comparison of thymocyte development and cytokine production in CD7-deficient, CD28-deficient and CD7/CD28 double-deficient mice.
- Costimulatory molecules are active in the human xenoreactive T-cell response but not in natural killer-mediated cytotoxicity.
- Early B-cell activation after West Nile virus infection requires alpha/beta interferon but not antigen receptor signaling.
- Engineering DNA vaccines via co-delivery of co-stimulatory molecule genes.
- Evaluation of CD86/CD28 and CD40/CD154 pathways in regulating monocyte-derived CD80 expression during their interaction with allogeneic endothelium.
- GPI-defective monocytes from paroxysmal nocturnal hemoglobinuria patients show impaired in vitro dendritic cell differentiation.
- GRP94 (gp96) and GRP94 N-terminal geldanamycin binding domain elicit tissue nonrestricted tumor suppression.
- Identifying regulatory B cells (B10 cells) that produce IL-10 in mice.
- Immunomodulator effect of picroliv and its potential in treatment against resistant Plasmodium yoelii (MDR) infection in mice.
- Induction therapy with monoclonal antibodies specific for CD80 and CD86 delays the onset of acute renal allograft rejection in non-human primates.
- Intracellular adhesion molecule-1 modulates beta-chemokines and directly costimulates T cells in vivo.
- Lymphadenopathy, splenomegaly, and altered immunoglobulin production in BCL3 transgenic mice.
- Modification of host dendritic cells by microchimerism-derived extracellular vesicles generates split tolerance.
- Release of endogenous danger signals from HIFU-treated tumor cells and their stimulatory effects on APCs.
- Repression of B7.2 on self-reactive B cells is essential to prevent proliferation and allow Fas-mediated deletion by CD4(+) T cells.
- Sequential delivery of maturation stimuli increases human dendritic cell IL-12 production and enhances tumor antigen-specific immunogenicity.
- T cell-mediated elimination of B7.2 transgenic B cells.
- The B7-2 (B70) costimulatory molecule expressed by monocytes and activated B lymphocytes is the CD86 differentiation antigen.
- The modulation of dendritic cell integrin binding and activation by RGD-peptide density gradient substrates.
- The use of self-adjuvanting nanofiber vaccines to elicit high-affinity B cell responses to peptide antigens without inflammation.
- Transient CD86 expression on hepatitis C virus-specific CD8+ T cells in acute infection is linked to sufficient IL-2 signaling.